Learning Hub Central

2026 APP | Role of Cardio-Oncology and When to Refer: A Breast Cancer Case Study

0.00 Credits

1 Chapter

Breast

Free

2026 CCC | Updates in Metastatic Triple Negative Breast Cancer

0.00 Credits

1 Chapter

Breast

Free

2026 CCC | Advances in Metastatic Hormone Receptor Positive Breast Cancer

0.00 Credits

1 Chapter

Breast

Free

2026 CCC | Updates in the Treatment of Triple Negative Early Stage & Locally Advanced Breast Cancer

0.00 Credits

1 Chapter

Breast

Free

2026 CCC | Advances in the Treatment of Hormone Receptor Positive Early Stage & Locally Advanced Breast Cancer

0.00 Credits

1 Chapter

Breast

Free

2026 CCC | Keynote Lecture: Accelerating Progress in Breast Cancer

0.00 Credits

1 Chapter

Breast

Free

2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (NO)

0.00 Credits

1 Chapter

Breast

Free

2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (YES)

0.00 Credits

1 Chapter

Breast

Free

2026 NOSCM | Understanding Disparities in Breast Cancer Diagnosis & Treatment in the US: Treatment, Toxicity and Clinical Trials

0.00 Credits

1 Chapter

Breast

Free

2026 NOSCM | Advances in the Treatment of TNBC: Optimal Treatment Strategy for Early and Late-stage Disease

0.00 Credits

1 Chapter

Breast

Free

2026 NOSCM | HER2 Positive Breast Cancer: Optimal Chemotherapy Combinations & Sequencing w/ Antibody Drug Conjugates & Role of Maintenance Therapy

0.00 Credits

1 Chapter

Breast

Free

2026 NOSCM | Advances in the Treatment of Hormone Receptor Positive Early-stage Breast Cancer: Optimal Sequencing, Use of Targeted Agents

0.00 Credits

1 Chapter

Breast

Free

2026 MaTOS Breast | Faculty PDF Access

0.00 Credits

31 Chapters

Breast

$100,000.00

2026 MaTOS Breast | Session XIV | Case Presentation Discussions

0.00 Credits

4 Chapters

Breast

Free

2026 MaTOS Breast | Session XIII | De-escalation of Surgery and Radiation: Less Invasive Approaches for Early-Stage Disease and Their Impact on Outcomes

0.00 Credits

4 Chapters

Breast

Free

2026 MaTOS Breast | Session IX | Keynote Presentation

0.00 Credits

1 Chapter

Breast

Free

2026 MaTOS Breast | Session VIII | Great Debates in Breast Cancer

0.00 Credits

6 Chapters

Breast

Free

2026 MaTOS Breast | Session VII | Cutting Edge Clinical Trial Designs in Breast Cancer

0.00 Credits

4 Chapters

Breast

Free

2026 MaTOS Breast | Session VI | Antibody-Drug Conjugates in Breast Cancer

0.00 Credits

5 Chapters

Breast

Free

2026 MaTOS Breast | Session V | Case-Based Panel Discussion

0.00 Credits

5 Chapters

Breast

Free

2026 MaTOS Breast | Session IV | Clinical Science Symposium: Therapeutic Strategies Targeting the Estrogen Receptor

0.00 Credits

6 Chapters

Breast

Free

2026 MaTOS Breast | Session III | Case-Based Panel Discussion

0.00 Credits

5 Chapters

Breast

$5,000.00

2026 MaTOS Breast | Session II | Targeting the Host Immune System in Breast Cancer

0.00 Credits

5 Chapters

Breast

Free

2026 MaTOS Breast | Session I | Clinical Science Symposium: Targeting the PI3 Kinase, AKT, mTOR Pathway

0.00 Credits

5 Chapters

Breast

$5,000.00

2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer

0.00 Credits

1 Chapter

Breast

Free

Contact Us

Learning Hub Central

Breast

2026 APP | Role of Cardio-Oncology and When to Refer: A Breast Cancer Case Study

2026 CCC | Updates in Metastatic Triple Negative Breast Cancer

2026 CCC | Advances in Metastatic Hormone Receptor Positive Breast Cancer

2026 CCC | Updates in the Treatment of Triple Negative Early Stage & Locally Advanced Breast Cancer

2026 CCC | Advances in the Treatment of Hormone Receptor Positive Early Stage & Locally Advanced Breast Cancer

2026 CCC | Keynote Lecture: Accelerating Progress in Breast Cancer

2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (NO)

2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (YES)

2026 NOSCM | Understanding Disparities in Breast Cancer Diagnosis & Treatment in the US: Treatment, Toxicity and Clinical Trials

2026 NOSCM | Advances in the Treatment of TNBC: Optimal Treatment Strategy for Early and Late-stage Disease

2026 NOSCM | HER2 Positive Breast Cancer: Optimal Chemotherapy Combinations & Sequencing w/ Antibody Drug Conjugates & Role of Maintenance Therapy

2026 NOSCM | Advances in the Treatment of Hormone Receptor Positive Early-stage Breast Cancer: Optimal Sequencing, Use of Targeted Agents

2026 MaTOS Breast | Faculty PDF Access

2026 MaTOS Breast | Session XIV | Case Presentation Discussions

2026 MaTOS Breast | Session XIII | De-escalation of Surgery and Radiation: Less Invasive Approaches for Early-Stage Disease and Their Impact on Outcomes

2026 MaTOS Breast | Session IX | Keynote Presentation

2026 MaTOS Breast | Session VIII | Great Debates in Breast Cancer

2026 MaTOS Breast | Session VII | Cutting Edge Clinical Trial Designs in Breast Cancer

2026 MaTOS Breast | Session VI | Antibody-Drug Conjugates in Breast Cancer

2026 MaTOS Breast | Session V | Case-Based Panel Discussion

2026 MaTOS Breast | Session IV | Clinical Science Symposium: Therapeutic Strategies Targeting the Estrogen Receptor

2026 MaTOS Breast | Session III | Case-Based Panel Discussion

2026 MaTOS Breast | Session II | Targeting the Host Immune System in Breast Cancer

2026 MaTOS Breast | Session I | Clinical Science Symposium: Targeting the PI3 Kinase, AKT, mTOR Pathway

2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer

Contact Us